Northwest Biotherapeutics
NWBO
NWBO was delisted on the 16th of December, 2016.
20 hedge funds and large institutions have $8.95M invested in Northwest Biotherapeutics in 2013 Q2 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
7.92% more ownership
Funds ownership: 0% → 7.92% (+7.9%)
Top Buyers
Top Sellers
NWBO Hedge Fund Activity: Q2 2013 in Review
20 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics (NWBO) for Q2 2013, worth a combined $8.95M.
Buyers outnumbered sellers: 20 funds opened new NWBO positions and 0 closed out — a net gain of 20 holders — while 0 added to existing stakes and 0 trimmed.
- 20 institutional investors held Northwest Biotherapeutics (NWBO) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $8.95M of Northwest Biotherapeutics stock for Q2 2013.
- 20 funds opened new Northwest Biotherapeutics positions in Q2 2013 and 0 closed out, a net change of +20 holders.
Based on aggregated 13F filings for Q2 2013.